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Abstract
Genomic instability at loci with tandem arrays of simple repeats is the cause for many neurological, neurodegenerative and
neuromuscular diseases. When located in coding regions, disease-associated expansions of trinucleotide repeats are
translated into homopolymeric amino acid stretches of glutamine or alanine. Polyalanine expansions in the poly(A)-binding
protein nuclear 1 (PABPN1) gene causes oculopharyngeal muscular dystrophy (OPMD). To gain novel insight into the
molecular pathophysiology of OPMD, we studied the interaction of cellular proteins with normal and expanded PABPN1.
Pull-down assays show that heat shock proteins including Hsp70, and type I arginine methyl transferases (PRMT1 and
PRMT3) associate preferentially with expanded PABPN1. Immunofluorescence microscopy further reveals accumulation of
these proteins at intranuclear inclusions in muscle from OPMD patients. Recombinant PABPN1 with expanded polyalanine
stretches binds Hsp70 with higher affinity, and data from molecular simulations suggest that expansions of the PABPN1
polyalanine tract result in transition from a disordered, flexible conformation to a stable helical secondary structure. Taken
together, our results suggest that the pathological mutation in the PABPN1 gene alters the protein conformation and
induces a preferential interaction with type I PRMTs and Hsp70 chaperones. This in turn causes sequestration in intranuclear
inclusions, possibly leading to a progressive cellular defect in arginine methylation and chaperone activity.
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Introduction
Tandem arrays of simple repeats such as mono-, tri-, and
tetranucleotides are common in eukaryotic genomes, and repeat
instability is the cause for more than 40 neurological, neurodegen-
erative and neuromuscular diseases [1]. Repeat instability is a
dynamic form of mutation that is most likely associated with DNA
replication, repair and recombination. Intriguingly, there is an
evolutionary trend towards longer trinucleotide repeats in humans
relative to other species [2]. The majority of repeat-associated
disorders are caused by expansions of trinucleotide repeats located in
either coding or non-coding regions of the genome. While noncoding
repeats may induce the generation of chromosome fragility, the
silencing of the genes in which they are located, the modulation of
transcription and translation, and the sequestering of proteins
involved in cellular processes, repeats in the coding sequence can
result in the generation of toxic or malfunctioning proteins. Disease-
associated expansions of coding DNA triplets are translated into
homopolymeric amino acid stretches of glutamine or alanine [3,4].
Approximately 500 human proteins are predicted to contain
polyalanine tracts, and disease-causing expanded alanine stretches
have been identified in nine of these proteins [4–6]. With a single
exception, all these proteins are transcription factors that play
important roles during development. The expansion mutations in
these transcription factors lead to a variety of symptoms including
mental retardation and malformations. The exception is poly(A)-
binding protein nuclear 1, PABPN1 (previously called PABP2), a
protein involved in polyadenylation of mRNA precursors [7].
Polyalanine expansion in PABPN1 causes oculopharyngeal muscular
dystrophy, OPMD [8]. OPMD is caused by expansions in a 6 GCG
trinucleotide repeat tract ([GCG]6) located in the first exon of the
PABPN1 encoding gene [9]. In the vast majority of patients the disease
is inherited with heterozygous mutation carriers displaying alleles in the
range from 2 to 7 additional GCG repeats [(GCG)8–13][ 9 ] .
Given the frequency of polyalanine stretches, their strong
evolutionary conservation, and the deleterious effects of their
expansion, it is likely that alanine tracts play an important role in
protein structure and function. Recent in vitro and in vivo data
suggest that expansions of polyalanine tracts beyond a certain
threshold result in protein misfolding and aggregation [4].
Here we show that the normal polyalanine stretch in PABPN1 is
predicted to be intrinsically unstructured and highly flexible,
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6418whereas peptides corresponding to the extended PABPN1 tend to
form a helical secondary structure. We further show that
expansions of the polyalanine tract result in increased association
with Hsp70 chaperones and type I arginine methyl transferases.
These findings raise the possibility that sequestration by expanded
PABPN1 may cause a progressive cellular defect in both protein
modifications by arginine methylation and chaperone activity.
Results
Identification of proteins that associate preferentially
with expanded PABPN1
In order to examine if polyalanine tract expansion affects the
binding of cellular proteins to PABPN1, we performed pull-down
experiments from cell extracts with immobilized PABPN1 variants
(Fig. 1). For this purpose, normal and expanded human PABPN1
was expressed in baculovirus system, purified and biotinylated.
Then, the biotinylated PABPN1 was immobilized on streptavidin-
agarose beads and incubated with extracts from undifferentiated
and differentiated C2 cells (Fig. 1A, B). Cell extracts were pre-
treated with RNase A to avoid detection of protein interactions
mediated by RNA. Cellular proteins that bound to the beads were
eluted and analyzed by SDS-PAGE. The gel bands that stained
with different intensities in the lanes corresponding to normal and
expanded PABPN1 were excised and proteins identified by mass
spectrometry (Fig. 1C). The results are summarized in Table 1,
which lists the number of unique peptides identified for each
protein in the different experiments.
Immunoblot analysis confirmed that PRMT1, PRMT3, Hsp70
and Hsp90 are more abundantly associated with expanded
PABPN1 relative to normal PABPN1, and similar results are
observed in undifferentiated and differentiated C2 cells (Fig. 1D).
In contrast, similar levels of Ski-interacting protein (SKIP), which
was previously identified as a PABPN1 interactor [10], are
detected in association with normal and expanded PABPN1.
However, the interaction between SKIP and PABPN1 is enhanced
Figure 1. Identification of proteins that associate preferentially with expanded PABPN1. (A) Purification strategy. Recombinant, His-
tagged PABPN1 containing either a normal homopolymer of 10 alanine residues or an expanded tract of 17 alanine residues was expressed in
baculovirus system and purified by nickel affinity. Normal and expanded PABPN1 were then biotinylated, immobilized to streptavidin-agarose beads
and incubated with RNase-treated extracts from undifferentiated C2 (myoblasts) and differentiated C2 (myotubes) cells. (B) Coomassie-stained SDS
polyacrylamide gel of purified recombinant HIS-PABPN1 used for pull-down experiments. (C) Bound proteins were eluted, separated by 10% SDS-
PAGE, and detected by silver staining. The gel bands that stained with higher intensity in the lanes corresponding to expanded PABPN1 were excised
and proteins identified by mass spectrometry. The identity of the bands is indicated. As a control, the same amount of extract was incubated with
beads devoid of any immobilized protein (control lanes). (D) Proteins bound to normal and expanded PABPN1 were eluted, separated by 10% SDS-
PAGE, blotted to nitrocellulose, and probed with the antibodies against the indicated proteins. Total protein from C2 cell extract (input) was run in
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consistent with the view that SKIP co-operates with PABPN1 to
stimulate myogenesis [10].
PRMT1 and PRMT3 are present in OPMD intranuclear
inclusions
As the major pathological hallmark of OPMD consists of
intranuclear inclusions formed by deposition of PABPN1 fibrils,
we next analyzed the sub-cellular distribution of proteins identified
as preferentially associated with expanded PABPN1. Immunoflu-
orescence was performed on muscle fibers from two OPMD
patients that have one normal PABPN1 allele (GCG6) and one
expanded allele (GCG11) coding for a protein with a polyalanine
tract of 15 residues. Typical intranuclear inclusions were detected
using anti-PABPN1 antibodies (Fig. 2A, D, G, J, M), and double-
labelling experiments reveal that both PRMT1 (Fig. 2B, C) and
PRMT3 (Fig. E, F) are concentrated in the inclusions. In contrast
to PRMT1 and PRMT3, which are protein arginine methyltrans-
ferases involved in the modification of PABPN1 [11,12], PRMT2,
which does not methylate PABPN1, is not detected in the
inclusions (Fig. 2H, I). The intranuclear inclusions are intensely
stained by anti-peptide antibodies that specifically recognize
asymmetrically dimethylated PABPN1 (Fig. 2K, L), but do not
react with antibodies specific to unmethylated PABPN1 (Fig. 2N,
O). These results indicate that pathological aggregates of PABPN1
consist of methylated protein and accumulate PRMT1 and
PRMT3.
Taking into account the biochemical evidence indicating that
PRMT1 and PRMT3 bind preferentially to expanded PABPN1,
one possibility is that these enzymes become sequestered in the
pathological PABPN1 aggregates. To address this view, we
estimated the fluorescence intensity corresponding to the sub-
nuclear distribution of PRMT1. The proportion of visible
intranuclear inclusions that stained positive for PRMT1 was
48% (n=60) and 41% (n=58) in patient #1 and patient #2,
respectively. In both patients, the intensity of PRMT1 fluorescence
was approximately two fold higher in the inclusions than in the
surrounding nucleoplasm (Fig. 2Q). Consistent with the seques-
tration hypothesis, the intensity of PRMT1 fluorescence was
significantly higher in the nucleoplasm of nuclei that do not
contain visible inclusions than in the nucleoplasm of nuclei with
inclusions (Fig. 2P).
Hsp70 accumulates in OPMD intranuclear inclusions and
binds with higher affinity to expanded PABPN1 in vitro
Having established that PRMT1 and PRMT3 associate
preferentially with expanded PABPN1 and concentrate in OPMD
intranuclear inclusions, we next examined the sub-cellular
distribution of Hsp70 and Hsp90 in muscle fibers from OPMD
patients. Immunofluorescence analysis revealed a clear concen-
tration of Hsp70 in the PABPN1 inclusions (Fig. 3), while
antibodies anti-Hsp90 did not stain these structures (not shown).
To further characterize the influence of polyalanine extension on
the interaction between Hsp70 and PABPN1, we performed
steady-state tryptophan fluorescence spectroscopy. PABPN1 has a
single tryptophan residue located in the C-terminal region that can
be used to monitor changes in the amino acid environment caused
by protein-protein interactions. Tryptophan emission fluorescence
spectra were recorded in response to the addition of increasing
amounts of purified recombinant Hsp70 to purified recombinant
normal and expanded PABPN1 variants. Contribution of Hsp70
to the fluorescence spectra was subtracted in all the cases. For each
PABPN1/Hsp70 complex, the relative dissociation constant (Kd)
was calculated (Fig. 3). The results show that, compared to normal
PABPN1, the interaction with Hsp70 is stronger for the expanded
protein with 14 alanines and even stronger for the expanded
variant with 17 alanines (Fig. 3). This suggests that the number of
residues in the polyalanine tract of PABPN1 correlates with the
binding affinity to Hsp70.
The polyalanine stretch is part of an intrinsically
unstructured segment within PABPN1
PABPN1 is a 306 amino acid protein and its primary structure
suggests a separation into four domains: an N-terminal segment
encompassing amino acids 2–112; a coiled-coil domain corre-
sponding to amino acids 116 to 151 [13,14]; a single RNA
recognition motif (RRM) corresponding to amino acids 173–245
and a C-terminal domain of approximately 49 amino acids (257–
306) (Fig. 4A). In order to bioinformatically analyze the presence
of ‘‘hot-spots’’ for protein aggregation within PABPN1 amino acid
sequence we used the AGGRESCAN server [15]. The algorithm
uses biological data from already known samples of aggregating
polypeptides to compute a score for the aggregation propensity of
a short amino acid region in a protein sequence. The results
obtained with normal PABPN1 sequence show that higher scores
for aggregation propensity are located within the RRM domain
Table 1. Mass spectrometry analysis of PABPN1-interacting
proteins.
NAME MW ACCESSION# PEPTIDES
Myoblasts Myotubes
wt exp wt exp
PRMT1 39 Q8C2D7 5 18 4 17
PRMT3 59 Q922H1 6 14 3 10
HSP70 1A 70 Q61696 3 21 5 19
HSP70 1B 70 P17879 2 15 6 14
Hsc73 70 JC4853 4 11 3 9
HSP70 1L 70 I49761 1 5 2 8
HSP90 alpha 84 P07901 4 11 6 16
HSP90 beta 83 P11499 4 10 7 19
Laminin receptor 1 32 Q8BNL2 1 1 2 1
CREB-binding protein 264 Q8QZV8 1 1 0 0
N-RAP 133 T37192 0 0 2 1
YBOX1 35 P62960 3 4 4 3
MYB-1 A 36 Q60950 2 5 6 4
MYB-1 B 35 Q60951 2 2 4 3
EF2 95 P58252 5 4 2 3
DDEF2 106 Q7SIG6 1 1 3 2
EF1A1 50 P10126 7 9 3 3
Gspt1 49 Q8BPH0 0 1 1 1
hnRNP U 87 O88568 9 8 7 8
IMPORTIN 7 119 Q9EPL8 3 3 2 1
PABPN1 32 Q8CCS6 6 5 6 6
SkiP 61 Q9CSN1 3 4 7 8
The number of unique peptides identified associated with normal (wt) PABPN1
is compared with the number of unique peptides identified associated with
expanded (exp) PABPN1 in undifferentiated (myoblasts) and differentiated
(myotubes) C2 cells. Accession # indicates UniProt accession numbers. MW
indicates the calculated molecular weight in kilodaltons.
doi:10.1371/journal.pone.0006418.t001
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PLoS ONE | www.plosone.org 3 July 2009 | Volume 4 | Issue 7 | e6418Figure 2. PRMT1 and PRMT3 accumulate in OPMD intranuclear inclusions. (A–O) Immunofluorescence was performed on biopsy samples
of quadriceps muscle from two OPMD patients using the indicated antibodies. Scale bar=5 mm. (P–Q) From each patient (OPMD1 and OPMD2),
approximately 60 nuclei labelled with anti-PRMT1 antibody were analyzed. The mean fluorescence intensity measured in the nucleoplasm is higher in
nuclei devoid of inclusions compared to nuclei with inclusions (P). The mean fluorescence intensity measured in the nuclear inclusions is
approximately two-fold higher than the intensity measured in the nucleoplasm of nuclei with inclusions (Q). Quantitative measurements of
fluorescence intensity were performed with Image J software and expressed in arbitrary units (AU). Results are presented as mean fluorescence
intensity6SE; p values (Student’s t-test) are indicated.
doi:10.1371/journal.pone.0006418.g002
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that normal PABPN1 is inherently aggregation-prone when
exogenously expressed and that mutations in the RRM prevent
aggregate formation [16]. The low score for aggregation
propensity detected in the N-terminal region (Fig. 4B) is also in
agreement with our observation that aggregation of exogenously
expressed PABPN1 is independent from the polyalanine stretch
[16]. In further agreement with this view, two recent studies
reported the structure of the RRM domain of nuclear poly(A)-
binding proteins and showed that this domain mediates formation
of protein dimers [17,18]. The region involved in interaction
between each protein subunit corresponds to higher scores in the
aggregation propensity profile (Fig. 4B, arrows).
To further examine the structural features of the N-terminal
segment of PABPN1, we used the IUpred server [19]. The results
reveal that this region of the protein is predicted not to fold into
well-defined, ordered tertiary structures but to correspond to an
intrinsically disordered segment (Fig. 4C). The region has a
combination of low overall hydrophobicity and low sequence
complexity that leads to propensity to be disordered [20,21]. In
fact, with the exception of the RRM domain, most of PABPN1
structure is predicted as unfolded or lacking a tertiary structure
under physiological conditions (Fig. 4C). Intrinsic disorder is a
unique feature that allows proteins to be very dynamic in their
structure and to participate in several pathways at the same time
through binding to multiple partners via high-specificity and low-
affinity interactions play an important role [22,23].
Polyalanine expansions are coupled with disorder-to-
order transitions
Next, we asked how an expansion in alanine residues may affect
the natively disordered structure of the N-terminal segment of
PABPN1 using molecular dynamics simulations. N-terminal
peptides from wtPABPN1 and extended variants, containing 10,
Figure 3. Hsp70 accumulates in OPMD intranuclear inclusions and binds with higher affinity to expanded PABPN1 in vitro. (A–F)
Immunofluorescence was performed on biopsy samples of quadriceps muscle from two OPMD patients using the indicated antibodies. Scale
bar=5 mm. Tryptophan emission fluorescence spectra were recorded in response to the addition of increasing amounts of purified recombinant
Hsp70 to purified recombinant normal (wt) and expanded PABPN1 variants. The graph depicts a double reciprocal plot of the increase of
fluorescence intensity at the maximum wavelength of PABPN1 variants in response to increasing concentrations of Hsp70. Concentration of PABPN1
variants was 100 mM. (m) wt-PABPN1, (N) 4Ala-PABPN1 and (&) 7Ala-PABPN1. RFI, relative fluorescence intensity. The estimated dissociation
constants (Kd) for each complex are indicated in the table.
doi:10.1371/journal.pone.0006418.g003
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1000 ps. Figure 5 shows several representative snapshots of the
molecular dynamics trajectory for each peptide. These snapshots
were selected to demonstrate typical changes of the peptide
structure along the simulation. The simulation results reveal that
10-alanine peptides are very flexible, with no preference for any
stable secondary structure. As the number of alanines increases
there is an increment of structured secondary elements along the
molecular dynamics trajectory. The most striking difference is
observed with the 15- and 17-alanine peptides, which form a short
alpha helical structure. Analyzing the evolution of the hydrody-
namic radius during the simulation shows that, in contrast to
peptides with 10 or 13 alanines, peptides with 15 or 17 alanines
rapidly evolve to a very compact structure characterized by an
abrupt decrease of the hydrodynamic radius of the molecule
(Fig. 6A). Analysis of the evolution of secondary structure as a
function of time in the simulation was determined by analysis of
the trajectories with GROMACS [24]. The results show that 10-
alanine peptides behave as a very flexible ensemble along the
whole simulation with the majority of the residues in coiled
structure (Fig. 6). The simulation with 13-alanine peptides starts
with a high content of amino acids in coiled conformation, but at
400 ps the system evolved in a different way, with a decrease of the
contribution of the coiled structure and an increase in the residues
present in bended fragments. This suggests the presence of a more
compact conformation but without any predominant secondary
structure elements. The simulation with either 15- or 17-alanine
peptides starts with a high content of flexible, non-structured
regions and evolves to a structured segment mainly constituted by
a helical secondary structure. Particularly interesting is the
presence of a stable helical fragment in the 17-alanine peptide at
the end of the simulation. This helical fragment is composed of 14
residues distributed by a main stretch of 8 amino acids in a-helix
structure and also by a small segment of 5 amino acids that forms a
typical 5a-helix (Fig. 6B). The 5a-helix is a subtype of helical
secondary structure in which each amino acid corresponds to a
87u turn in the helix (i.e., the helix has 4.1 residues per turn), and a
translation of 1.15 A ˚ along the helical axis, being more expanded
and flexible than a common a-helix [25]. In conclusion, data from
molecular simulations suggest that expansions of polyalanine tracts
result in transition from a disordered, flexible conformation to a
stable helical secondary structure.
Polyalanine expansion associates with increased protein
hydrophobicity
The predicted conformational transitions caused by alanine
expansions are expected to increase hydrophobicity of mutant
PABPN1 proteins, thereby contributing to the increased affinity
for Hsp70 binding. To experimentally test this view, we measured
the exposure of hydrophobic domains in normal (wt) and
expanded (7Ala) PABPN1 by means of 1-Anilino naphthalene-8-
sulfonic acid (1,8-ANS) fluorescence analysis. 1,8-ANS is a
fluorescent probe that exhibits an increased and blue-shifted
emission upon binding to exposed hydrophobic patches [26].
Analysis of the emission spectrum of 1,8-ANS bound to normal
and expanded PABPN1 is shown in Figure 7. Consistent with the
predicted abundant intrinsic unstructured regions in PABPN1
(Fig. 4), the position of the maximum of emission (lmax) obtained
Figure 4. Computational analysis of PABPN1 structure. (A) Domains and structural elements in PABPN1 protein sequence. (B) Analysis of the
aggregation propensity performed by AGGRESCAN server [15]. Hot-spots determined by the server are marked with arrows. (C) Prediction of
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red-shifted in relationship to the range (about 468–477 nm)
usually reported for globular proteins with a stable tertiary
structure [27]. Noteworthy, lmax for 1,8-ANS bound to 7Ala-
PABPN1 (485 nm) showed a blue-shift compared with lmax for
1,8-ANS bound to wt-PABPN1 (493 nm). Moreover, binding of
1,8-ANS to 7Ala-PABPN1 resulted in increased emission intensity
compared with binding of 1,8-ANS to wt-PABPN1 (Fig. 7A).
Estimation of dissociation constants from fluorescence spectrosco-
py data (Fig. 7B) revealed that 1,8-ANS binds to expanded
PABPN1 with approximately two-fold more affinity (Kd=42 mM)
than it binds to normal PABPN1 (Kd=75 mM). Taken together
these results show that compared to normal PABPN1, the mutant
protein contains an increased amount of exposed hydrophobic
patches to the surface of the protein.
Discussion
Using a biochemical approach, we have identified two classes of
proteins that bind differentially to PABPN1 containing either
normal or expanded polyalanine tracts. One class comprises
protein arginine methyl transferases 1 and 3 (PRMT1 and
PRMT3), two enzymes responsible for methylation of arginine
residues in the C-terminal domain of PABPN1 [11,12,28].
PRMT1 and PRMT3 belong to the so-called type I PRMTs,
which catalyze asymmetrical dimethylation of arginine residues,
whereas type II PRMTs catalyze symmetrical dimethylation [29].
Most substrates for type I enzymes bind RNA, including
heterogeneous nuclear RNA binding proteins (hnRNPs), which
collectively account for 65% of the nuclear asymmetric dimethy-
larginine [30]. PRMT1 is the predominant type I enzyme in
tissues [31]. Murine embryos deficient in PRMT1 fail to develop,
indicating a fundamental role for the protein, but Prmt1
2/2 cells
are viable [32]. Consistent with some functional redundancy,
PRMT3 and PRMT6 suffice to methylate PABPN1 in Prmt1
2/2
cells [12]. PRMTs have been implicated in a wide variety of
cellular processes, but the biochemical and biological functions of
asymmetrical arginine dimethylation remain largely unknown
[29]. Here, we found that PRMT1 and PRMT3 associate
preferentially with expanded PABPN1 and become accumulated
at OPMD intranuclear inclusions. This raises the possibility that
binding of methyltransferases to expanded PABPN1 accumulated
in nuclear inclusions leads to a decreased availability of the
enzymes in the nucleoplasm, which may in turn reduce the
methylation status of other cellular targets. We therefore
hypothesize that defects in asymmetrical arginine dimethylation
secondary to sequestration of PRMT1 and PRMT3 in nuclear
inclusions may contribute to the pathophysiology of OPMD.
Heat shock proteins represent another class of proteins that we
found preferentially associated with expanded PABPN1 and
concentrated at OPMD intranuclear inclusions. Hsp70 molecular
chaperones play diverse roles in cells and all such functions are
Figure 5. Molecular dynamics snapshots of normal and expanded PABPN1 N-terminal peptides. Conformational behavior of peptides
corresponding to the N-terminal segment of PABPN1 variants were studied by molecular dynamics simulation during a time scale of 1000 ps. The
figure shows selected snapshots along the molecular dynamics simulation trajectory for wild-type (wt) PABPN1 and expanded variants with 3, 5 and 7
additional alanines. Sequences of the peptides are indicated at the top of the table. Figure prepared with PyMol [52].
doi:10.1371/journal.pone.0006418.g005
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PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6418Figure 6. Conformational characteristics of normal and expanded PABPN1 N-terminal peptides. (A) Evolution of the hydrodynamic
radius along the molecular dynamics simulation trajectory for wild-type (wt) PABPN1 and expanded variants. (B) Evolution of secondary structure
elements along the molecular dynamics trajectories performed by DSSP [53,54] for wild-type (wt) PABPN1 and expanded variants. Each type of
secondary structure element is represented in a different color. The number of amino acids belonging to each secondary structure type is
represented versus the simulation time.
doi:10.1371/journal.pone.0006418.g006
PABPN1 Interacting Proteins
PLoS ONE | www.plosone.org 8 July 2009 | Volume 4 | Issue 7 | e6418mediated by interaction of extended, hydrophobic regions of
substrate proteins with the Hsp70 C-terminal substrate-binding
domain [33]. Here we show biochemically that Hsp70 binds with
higher affinity to expanded PABPN1 in vitro, and that binding
affinity is proportional to the length of the polyalanine stretch. We
further show that the normal polyalanine stretch in PABPN1 is
predictably intrinsically unstructured and highly flexible, whereas
alanine expansion causes a disorder-to-order conformational
transition. A major change involving formation of a stable helical
secondary structure is predicted to take place when the
polyalanine stretch expands to 15 or 17 residues. By increasing
hydrophobicity, as confirmed by 1,8-ANS-fluorescence analysis,
these changes most likely contribute to the increased affinity for
Hsp70 binding.
Several neurodegenerative disorders including Alzheimer,
Parkinson and Huntington diseases, amyotrophic lateral sclerosis
and spinocerebellar ataxias are associated with the formation of
non-native protein structures that have been described as
oligomers, aggregates, plaques or inclusions. These are thought
to result from the combined expression of misfolded proteins and
disruption of protein folding quality control [34]. Molecular
chaperones such as Hsp70 are detected in disease-related non-
native protein structures, and it has been suggested that this
interaction reflects the efforts of Hsp70 to dissociate the aggregates
[35]. In this study we provide novel evidence supporting this view.
Our results suggest that Hsp70 molecular chaperones become
trapped by aggregates of expanded PABPN1 in muscle cell nuclei.
Possibly, recruitment of Hsp70 chaperones to expanded PABPN1
reflects an effort to prevent aggregate formation and/or to
dissociate the protein from aggregates. However, as this protective
effort fails and larger nuclear inclusions accumulate in the nucleus,
a progressively larger proportion of molecular chaperones may be
sequestered in the PABPN1 aggregates, thus decreasing the
proportion of chaperones available to perform other essential
functions in the cell. This would aggravate the diminished capacity
of heat shock gene induction that seems to occur later in life [34].
In conclusion, this study highlights two novel mechanisms that
may contribute to OPMD. By interacting preferentially with
expanded PABPN1, type I PRMTs and Hsp70 chaperones are
sequestered in pathological nuclear inclusions. Consequently, cells
may become progressively defective in asymmetrical arginine
dimethylation activity and in heat shock response. Defects caused
by impaired type I PRMT activity could be expected at the level of
signal transduction pathways to regulate gene expression and cell
proliferation, whereas diminished chaperone activity could
impinge on protein translation, import of proteins into organelles,
response to stress and protein folding quality control.
Our data further reveal that the normal polyalanine stretch in
PABPN1 is predicted to be intrinsically unstructured and highly
flexible. In contrast, peptides corresponding to the extended
PABPN1 variants N-terminal regions and containing 15 or 17
alanine residues tend to form a helical secondary structure. The
polyalanine expansion in the N-terminal peptide of PABPN1
induces the formation of an alpha-helical segment proportional in
size to the number of alanines in expansion. This ordered alpha
helical segment is located within a predicted unfolded protein
section that comprises the first 112 amino acids, and that has been
involved in PABPN1 interaction with other proteins [36,37].
Interestingly, molecular dynamics data also showed the presence
of a 5a-helix (also known as p-helix) in the 7Ala-expanded
PABPN1 N-terminal peptide simulations. This p-helices are more
expanded and higher-entropy structures than a classical a-helix
and have been involved in certain specific protein-protein
interactions [25]. The presence of this helical-segment in
expanded variants of PABPN1 could modulate their interactions
properties by changing partner specificity and/or affinity.
We show that Hsp70 binds with higher affinity to pathologically
expanded PABPN1 and associates with intranuclear inclusions
characteristic of OPMD muscle fibers. Based on data analysis from
molecular simulations we propose that expansions of the PABPN1
polyalanine tract beyond a certain threshold result in transition
from a disordered, flexible conformation to a stable helical
secondary structure that enhances the binding to Hsp70. It is well
known that molecular chaperones are cellular helpers for protein
folding. Specifically, Hsp proteins are known to interact with
nascent polypeptides and hydrophobic protein chains to promote
Figure 7. Effect of alanine expansion on exposure of PABPN1 hydrophobic domains. (A) The degree of exposure of hydrophobic domains
was determined by 1,8-ANS fluorescence analysis. Fluorescence emission spectra of 1,8-ANS (5 mM) either free (a) or bound to 5 mM recombinant wt-
PABPN1 (b) and 5 mM recombinant 7Ala-PABPN1 (c). (B) Determination of the dissociation constants (Kd) for the complexes between 1,8-ANS and
PABPN1 variants. (m) wt-PABPN1 and (&) 7Ala-PABPN1 RFI, relative fluorescence intensity.
doi:10.1371/journal.pone.0006418.g007
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PABPN1 could act as a signal to promote a misfolding response.
This could be due to the presence of a hydrophobic and structured
alpha-helical fragment (constituted by the expanded polyalanine
stretch) within a hydrophilic N-terminal region. This signal could
recruit specific chaperones, mainly belonging to the Hsp family,
and cause a misbalance in the levels of these molecules that could
be accumulative on time. Furthermore, the formation of this stable
alpha helix in the N-terminal region of PABPN1 due to the
pathological expansion could be also responsible for the
misregulation in the binding specificity of PABPN1 to some of
its physiological partners. Indeed, it is well known that protruding
alpha helices and more in detail polyalanine stretches are
abundant in higher eukaryotes and they are proposed to be
involved in regulatory networks mediating protein-protein inter-
actions [39].
Although the aggregative behavior of expanded PABPN1
protein has been proposed as the cause of OPMD, a propensity
to aggregate is not exclusive of the expanded protein and can also
be observed in normal PABPN1 [16,40-43]. Based on the evidence
reported here, we propose that polyalanine tract expansions alter
the protein conformation and change the binding properties of
interacting proteins independently of the formation of intranuclear
inclusions. Together with protein aggregation, this likely repre-
sents an additional mechanism contributing to the disease. Indeed,
evidence that mutant proteins can induce neurodegeneration by
an apoptotic mechanism in the absence of nuclear inclusions was
first reported in a cellular model of Huntington’s disease [44]. The
concept that proteotoxicity of expanded PABPN1 is caused by
altered protein networking has important implications for the
development of novel therapeutic strategies, such as druggable
modifiers of altered protein function [45].
Materials and Methods
Pull-down assays with biotinylated proteins
The normal and expanded forms of recombinant PABPN1
purified from insect cells (see supplementary material S1 for
details) were biotinylated using EZ-Link PEO-Maleimide Activat-
ed Biotin (Pierce), according to the manufacturer’s instructions.
Buffer exchange to remove unincorporated PEO-biotin was
performed using NAP-5 or NAP-10 columns (Pharmacia Biotech).
For each binding reaction, 15 ml of streptavidin-agarose beads
(Sigma-Aldrich) was presaturated with biotinylated PABPN1
(2 mg) diluted in 20 mM Tris, pH 8.0, 200 mM KCl and 10%
glycerol. The beads were washed three times with 20 mM Tris,
pH 8.0, 200 mM KCl, 10% glycerol, and incubated in the same
buffer supplemented with 100 ml of C2 cell extract in a total
volume of 150 ml for 4 h at 4uC. The beads were then washed
three times with 20 mM Tris, pH 8.0, 200 mM KCl, 10%
glycerol, followed by three further washes with 50 mM Tris,
pH 7.5, 150 mM potassium acetate, and 2 mM MgCl2, and a
final wash in 50 mM Tris, pH 7.5. Bound proteins were eluted in
20 ml of SDS sample buffer and analyzed by SDS-PAGE and
Western blotting.
Cell culture and preparation of cell extracts
SF21 cells (an insect cell line highly susceptible to infection with
baculovirus) were cultured in suspension in SF-900 II SFM
medium (Invitrogen, Paisley, Scotland). C2 cells (a murine
myogenic cell line derived from perinatal mouse skeletal muscle)
were cultured as monolayer in Dulbecco’s Modified Eagle’s
Medium (DMEM; Gibco Life Technologies, Rockville, MD)
supplemented with 20% FCS. Cells were grown at 37uCi na
humidified atmosphere containing 5% CO2 and maintained at
sub-confluence to proliferate. To induce differentiation, C2 cells
were plated at a density of 4610
6 cells per 35 mm culture dish and
grown to confluence for 24 h. The medium was then changed to
DMEM supplemented with 2% horse serum (GIBCO), and
replaced every two days. Four days after culture in differentiation
medium, C2 cells formed myotubes that stained positive for
myosin heavy chain, a late marker of muscle differentiation.
Frozen C2 cell pellets were resuspended and incubated in
20 mM Tris pH 8.0, 500 mM NaCl, 0.1% NP40, 0.1%
Deoxycholate, 0.1% Triton X-100 and protease inhibitors, for
1 h at 4uC. The extracts were clarified by centrifugation for
45 min at 14000 rpm, and then digested with 0.5 mg/ml RNase A
(Sigma-Aldrich), for 1 hour at 37uC. After RNase treatment,
extracts were dialyzed to 20 mM Tris pH 8.0, 200 mM KCl and
10% glycerol, for 5 h, and then cleared by centrifugation.
Protein Identification by Mass-Spectrometry
Cellular proteins that bound to biotinylated PABPN1 immobi-
lized on streptavidin-agarose beads were eluted, separated by
SDS/PAGE, and stained either with Coomassie blue or silver
staining. The protein bands of interest were excised from the gel
and were analyzed by matrix-assisted laser desorption/ionization
MS (MALDI-MS) and identified in the National Center for
Biotechnology Information non-redundant database by using
MASCOT (Matrix Science, London) as a search engine.
SDS-PAGE and immunoblotting
SDS-PAGE and Western blotting were performed as previously
described [46]. Proteins were separated by SDS-PAGE on 10%
polyacrylamide minigels (BioRad Laboratories, Richmond, Cali-
fornia) and electroblotted to a nitrocelulose membrane. Mem-
branes were washed in PBS, blocked with PBS 5% low fat milk for
at least 1 h and incubated with specific primary antibodies diluted
in PBS 2.5% low fat milk at 4uC overnight. Membranes were then
washed 3615 minutes in PBS-Tw 2.5% low fat milk, incubated
with appropriated secondary antibodies conjugated with horse-
radish peroxidase (BioRad Laboratories, Richmond, California)
and developed using a chemiluminescence reaction (ECL;
Amersham Buchler GmbH, Braunschweig, Germany).
Immunofluorescence
Immunofluorescence was performed on biopsy samples from
vastus medialis (quadriceps) from two OPMD patients, after
appropriate informed consent. Tissue samples were embedded in
diethylene glycol and 1 mm thick sections were processed as
previously described [47].
Antibodies
The following primary antibodies were used in this study: rabbit
polyclonal serum anti-PABPN1 [48]; mouse polyclonal serum
raised against recombinant human PABPN1 [49]; rabbit anti-
peptide antibodies recognizing asymmetrically methylated and
unmethylated PABPN1 [12]; mouse monoclonal anti-SKIP
antibody (Sigma Aldrich., St Louis, MO), rabbit polyclonal anti-
Hsp70 antibody (Abcam and Stressgene) and rabbit polyclonal
anti-Hsp 90 antibody (Abcam); rabbit polyclonal antibodies anti-
PRMT1, anti-PRMT2 and anti-PRMT3 [12,50].
In vitro interactions of PABPN1 with Hsp70 by
fluorescence spectroscopy
Fluorescence spectroscopy studies were performed with recom-
binant PABPN1 variants expressed and purified from E.coli, and
PABPN1 Interacting Proteins
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supplementary material S1 for details) in a FS920 Steady-state
fluorescence spectrophotometer from Edinburgh Instruments. The
protein samples in interaction buffer (25 mM HEPES buffer,
pH 7.5, 100 mM NaCl and 1 mM dithiothreitol) were gently
stirred at 30uC, excited with a 285-nm light in a quartz cuvette
and the emission spectra recorded (scan speed 1 nm/s and
bandwidth 5 nm). All studies were made using steady-state
fluorescence conditions and the fluorescence contribution of the
solvent was subtracted in each sample.
Kinetic studies for determination of the affinity constants were
carried out as described previously [51]. Assuming a simple
association model between PABPN1 and Hsp70 with a 1 to 1
stochiometry, the dissociation constant Kd of the complex could
be defined as Kd=[PABPN1]6[Hsp70]/[PABPN1-Hsp70]. This
constant may be expressed with a double-reciprocal plot equation
as a function of the modification of the fluorescence intensities of













Where DF is the increase of PABPN1 fluorescence originated by a
specific concentration of Hsp70, and DFtot the maximum increase
of PABPN1 fluorescence intensity induced by a saturation
concentration of Hsp70 corrected by taking into account the
fluorescence modifications induced by the solvent and the added
Hsp70 protein alone [51].
Molecular dynamics simulation of N-terminal PABPN1
peptides
All simulations were performed with the GROMACS package
and the all atom GROMOS96 force field [24]. The models used
in the simulation were the N-terminal peptides of wild-type
PABPN1 protein and extended variants with 3, 5 and 7 Ala
extensions as they appeared in OPMD disease. Sequences of each
analyzed peptide were for the wild-type PABPN1 N-terminal
peptide: M-(A)10-GAAGGRG, for 3-Ala expanded: M-(A)13-
GAAGGRG, for the 5-Ala expanded: M-(A)15-GAAGGRG and
for the 7-Ala expanded: M-(A)17-GAAGGRG. All the simulations
were started with fully extended conformations of the peptides
with a protonation of side chain consistent with a pH=7. Peptides
were solvated in a water box of 70670670 A ˚ and a density of 1 g/
cm
3. The solvated models were energy minimized by conjugated
gradient for 1000 steps to eliminate steric clashes between atoms.
All the systems were equilibrated by simulated annealing with slow
temperature decreasing from 2500 K to 300 K over 1000 cycles.
Molecular dynamics simulations were then performed over
1000 ps at 300 K and data collected every 1 ps.
Conformational probing with fluorescence ligands
Conformational analysis was performed using 1-Anilino naph-
thalene-8-sulfonic acid (1,8-ANS), a probe that detects exposed
hydrophobic domains of proteins. Recombinant PABPN1 protein
concentration was 5 mM in 25 mM HEPES buffer, pH 7.5,
100 mM NaCl and 1 mM dithiothreitol. 1,8-ANS was added (final
concentration 5 mM) to a solution containing the protein or the
buffer only (blank). After a 5-minute incubation, fluorescence
emission of 1,8-ANS was scanned from 400 to 650 nm at an
excitation wavelength of 380 nm, at 25uC. All experiments were
performed with a FS920 Steady-state fluorescence spectropho-
tometer from Edinburgh Instruments. The band pass was 5 nm
for both excitation and emission wavelengths. Means of 5
repetitive scans were recorded for each measurement. The kinetic
parameters of the interaction between probe and PABPN1 were
estimated using a previously described model [26].
Supporting Information
Supplementary Material S1 Supplementary material and
methods, covering details related with the cloning, expression
and purification protocols of Hsp70 chaperone and PABPN1
variants in insect cells, E.coli and Pichia pastoris.
Found at: doi:10.1371/journal.pone.0006418.s001 (0.04 MB
DOC)
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